Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaGrep is a leading quantitative trading and investment firm specializing in algorithmic and systematic trading strategies across global asset classes. The company also operates an asset management vertical in India with SEBI approval to sponsor mutual funds. It manages over Rs 8,500 crore globally and has launched successful quant-driven funds such as the AlphaMine Absolute Return Fund.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaGrep.